The physician’s viewpoint Part 2

Dr Päivi Paldánius outlines what is meant by clinical inertia, its impact on type 2 diabetes management as well as providing some more information on the Time2DoMore initiative.

If you liked this, click here to see Dr Paivi Paldánius discuss 10 years of vildagliptin and explore its use in early-diagnosed or elderly patients.

Back to Time 2 Do MoreTM in diabetes
Login/ Register Maximise Minimise